These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 29443623)

  • 1. Calprotectin and the Initiation and Progression of Head and Neck Cancer.
    Argyris PP; Slama ZM; Ross KF; Khammanivong A; Herzberg MC
    J Dent Res; 2018 Jun; 97(6):674-682. PubMed ID: 29443623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular calprotectin (S100A8/A9) facilitates DNA damage responses and promotes apoptosis in head and neck squamous cell carcinoma.
    Argyris PP; Saavedra F; Malz C; Stone IA; Wei Y; Boyle WS; Johnstone KF; Khammanivong A; Herzberg MC
    Oral Oncol; 2023 Feb; 137():106304. PubMed ID: 36608459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular calprotectin (S100A8/A9) controls epithelial differentiation and caspase-mediated cleavage of EGFR in head and neck squamous cell carcinoma.
    Argyris PP; Slama Z; Malz C; Koutlas IG; Pakzad B; Patel K; Kademani D; Khammanivong A; Herzberg MC
    Oral Oncol; 2019 Aug; 95():1-10. PubMed ID: 31345374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC.
    Khammanivong A; Sorenson BS; Ross KF; Dickerson EB; Hasina R; Lingen MW; Herzberg MC
    Oncotarget; 2016 Mar; 7(12):14029-47. PubMed ID: 26883112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma.
    Khammanivong A; Wang C; Sorenson BS; Ross KF; Herzberg MC
    PLoS One; 2013; 8(7):e69395. PubMed ID: 23874958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A8/A9 regulates MMP-2 expression and invasion and migration by carcinoma cells.
    Silva EJ; Argyris PP; Zou X; Ross KF; Herzberg MC
    Int J Biochem Cell Biol; 2014 Oct; 55():279-87. PubMed ID: 25236491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High S100A8 and S100A12 protein expression is a favorable prognostic factor for survival of oropharyngeal squamous cell carcinoma.
    Funk S; Mark R; Bayo P; Flechtenmacher C; Grabe N; Angel P; Plinkert PK; Hess J
    Int J Cancer; 2015 May; 136(9):2037-46. PubMed ID: 25302747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and function of S100A8/A9 (calprotectin) in human typhoid fever and the murine Salmonella model.
    De Jong HK; Achouiti A; Koh GC; Parry CM; Baker S; Faiz MA; van Dissel JT; Vollaard AM; van Leeuwen EM; Roelofs JJ; de Vos AF; Roth J; van der Poll T; Vogl T; Wiersinga WJ
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003663. PubMed ID: 25860480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A9 has a protective role in inflammation-induced skin carcinogenesis.
    McNeill E; Hogg N
    Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A8 and S100A9 in inflammation and cancer.
    Gebhardt C; Németh J; Angel P; Hess J
    Biochem Pharmacol; 2006 Nov; 72(11):1622-31. PubMed ID: 16846592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of S100A8 and S100A9 expression in gastric cancer].
    Hu Y; Fan B; Zhang LH; Cheng XJ; Niu ZJ; Ji JF
    Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3369-74. PubMed ID: 24418034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of S100A8, S100A9 and calprotectin levels in bladder cancer.
    Yasar O; Akcay T; Obek C; Turegun FA
    Scand J Clin Lab Invest; 2017 Oct; 77(6):437-441. PubMed ID: 28609200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast IMAC purification of non-tagged S100A8/A9 (calprotectin) from Homo sapiens and Sus scrofa.
    Hau JL; Kremser H; Knogl-Tritschler S; Stefanski V; Steuber J; Fritz G
    Protein Expr Purif; 2023 Aug; 208-209():106275. PubMed ID: 37084837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A8/A9 Induced by Interaction with Macrophages in Esophageal Squamous Cell Carcinoma Promotes the Migration and Invasion of Cancer Cells via Akt and p38 MAPK Pathways.
    Tanigawa K; Tsukamoto S; Koma YI; Kitamura Y; Urakami S; Shimizu M; Fujikawa M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Am J Pathol; 2022 Mar; 192(3):536-552. PubMed ID: 34954212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A8/A9 activate key genes and pathways in colon tumor progression.
    Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
    Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo.
    Grebhardt S; Müller-Decker K; Bestvater F; Hershfinkel M; Mayer D
    J Cell Physiol; 2014 May; 229(5):661-71. PubMed ID: 24122301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products.
    Iotzova-Weiss G; Dziunycz PJ; Freiberger SN; Läuchli S; Hafner J; Vogl T; French LE; Hofbauer GF
    PLoS One; 2015; 10(3):e0120971. PubMed ID: 25811984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment.
    Kim JH; Oh SH; Kim EJ; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
    Biochem Biophys Res Commun; 2012 Jun; 423(1):60-6. PubMed ID: 22634002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [S100A8/A9 and periodontal inflammatory diseases].
    Gao HY; Meng HX; Hou JX
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Sep; 55(9):679-684. PubMed ID: 32878406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
    Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
    Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.